Journal article
Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
- Abstract:
-
Background
We identified anti-obesity medications withdrawn since 1950 because of adverse drug reactions after regulatory approval, and examined the evidence used to support such withdrawals, investigated the mechanisms of the adverse reactions, and explored the trends over time.
Methods
We conducted searches in PubMed, the World Health Organization database of drugs, the websites of drug regulatory authorities, and selected full texts, and we hand searched refere...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Bibliographic Details
- Publisher:
- BioMed Central Publisher's website
- Journal:
- BioMed Central Medicine Journal website
- Volume:
- 14
- Issue:
- 1
- Pages:
- 191
- Publication date:
- 2016-11-01
- Acceptance date:
- 2016-10-27
- DOI:
- ISSN:
-
1741-7015
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:664392
- UUID:
-
uuid:a9a62c84-0ae7-4a40-a15e-f9d53ad03bf4
- Local pid:
- pubs:664392
- Source identifiers:
-
664392
- Deposit date:
- 2017-03-08
Terms of use
- Copyright holder:
- Heneghan et al
- Copyright date:
- 2016
- Notes:
- © The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record